ClinicalTrials.gg
Active, not recruitingNCT02732834Updated Feb 5, 2026

Clinician-Patient Communication in Lung Cancer Care

An observational study in Lung Cancer, sponsored by Memorial Sloan Kettering Cancer Center. Active, not recruiting at 7 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-05.

Sponsored by Memorial Sloan Kettering Cancer Center · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
294
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 108 studies in Lung Neoplasms by Memorial Sloan Kettering Cancer Center — 9 open to participants now, 20 under way, none of them phase 3. Lung Neoplasms · Memorial Sloan Kettering Cancer Center.

Enrollment
4th of 30
294 · median 78
Started
2016
with 2 others
Observational
30 of 108
3 open now
Primary completion
2027-01
later than 1 of 19 live
Registered
85th of 108
by date

Among the 108 studies in Lung Neoplasms by Memorial Sloan Kettering Cancer Center, this one is the 4th largest by enrollment of the 30 observational ones that give a count, is one of 3 that started in 2016, is one of 30 observational ones, reaches primary completion later than 1 of the 19 other live ones, and was the 85th registered.

Lung Neoplasms

5,436 studies on the registry are indexed under Lung Neoplasms; 1,350 are open to participants now.

Browse Lung Neoplasms studies →

Open to participants now

9 of the 108 studies in Lung Neoplasms by Memorial Sloan Kettering Cancer Center are open now, in 2 countries. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 997 Lung Neoplasms studies recruiting now, 686 (69%) set no upper age limit and 143 (14%) stop at 75 or younger; 45 take children under 18; 143 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 108 studies in Lung Neoplasms by Memorial Sloan Kettering Cancer Center, or all of them as a file.
02

Study summary

The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.

03

Conditions studied

  • Lung Cancer

Browse trials for

Keywords

  • Clinician-Patient Communication
  • 16-001
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

MSK thoracic clinic, pulmonary clinic

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with confirmed lung cancer diagnosis or mass suspicious of lung cancer as per clinician report and/or EMR
  • Lung cancer diagnosis or suspicious mass as per clinician report/EMR within 0-6 months of consent or within no more than three visits to participating clinician
  • Participating clinician approves his/her patient's participation in this study per clinician report.
  • Former (at least 100 cigarettes in lifetime and quit more than 30 days prior to enrollment) or current smoker (lifetime smoker who reports cigarette smoking within the past 30 days) as per self report or EMR;
  • English fluency (determined through EMR or clinician report), as we do not have the resources to translate the consultations from other languages or the surveys to other languages;
  • Patients must be 18 years old or older

Clinician Inclusion Criteria:

  • An MSK attending physician (radiologists, medical oncologists, and surgeons), Nurse Practitioner (NP), Physician Assistant (PA), Fellow, Resident or Clinical Nurse Specialist (CNS) or Clinical Nurse (RN) who is a member of the Thoracic Disease Management Team or Pulmonary Service currently treating thoracic patients at MSK as per self report
  • Clinical has individual clinic consultations to discuss adult health assessment and/or smoking history with the target patient population: English-speaking, at least 18 years of age, has a suspicious lung mass or confirmed diagnosis, is a former/current smoker, has had no more than 3 visits with clinician or had diagnosis in past 6 months as per self-report.

Exclusion criteria

Exclusion Criteria:

Clinician Exclusion Criteria

  • N/A
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
294 participants (actual)
Patient registry
No

Groups and cohorts

  • Part 1: Lung patients

    Following informed consent, the patient will complete the patient questionnaire, either electronically, by phone, or on paper. Patients who prefer to complete the survey electronically will be emailed a link to access to a secure electronic (web-based) version of the study assessment which they will have access to from any computer. We will include an introductory email with the survey link. Will audio-record actual patient-physician clinical consultations with lung cancer patients at Memorial Sloan Kettering (MSK). Completing the survey will take about 15 minutes. Answer a few open-ended questions about the consultation with the doctor. We will audio record your answers to these questions. This will take about 15 minutes.

    Behavioral: Questionnaire · Behavioral: Patient Interview · Behavioral: Audio recordings of clinical consultations

  • Part 1: Thoracic physicians and clinicians

    Will have 5 visits/consultations with their patients audio recorded.

    Behavioral: Audio recordings of clinical consultations

  • Part 2: Lung patients

    Following informed consent, the patient will complete the patient questionnaire, either electronically, by phone, or on paper. Patients who prefer to complete the survey electronically will be emailed a link to access to a secure electronic (web-based) version of the study assessment which they will have access to from any computer. Completing the survey will take about 15 minutes.

    Behavioral: Questionnaire

  • Part 2: Thoracic and pulmonary clinicians

    Following informed consent, clinicians will be scheduled to participate in a 2 hour training on empathic communication with lung cancer patients. Surveys will be collected from 6 patients (3 pre-training, 3 post-training). Clinicians will complete one standardized patient assessment before training (pre-SPA) and one assessment after training (post-SPA). These are 12-minute video-recorded clinic consultations with standardized patients (trained actors).

    Behavioral: 2-hour empathic communication skills training · Behavioral: Standardized Patient Assessments · Behavioral: Training evaluation · Behavioral: Patient recruitment

Interventions

  • BehavioralQuestionnaire

    patients will fill out a questionnaire about their perceived stigma, satisfaction with communication, and psychological distress.

  • BehavioralPatient Interview

    Then they will participate in a brief in-person interview about their perceived stigma during the clinical consultation

  • BehavioralAudio recordings of clinical consultations
  • BehavioralQuestionnaire

    Patients will fill out a questionnaire about their perceived stigma and satisfaction with their clinician's communication.

  • Behavioral2-hour empathic communication skills training

    2-hour empathic communication skills training

  • BehavioralStandardized Patient Assessments

    pre-training SPA, post-training SPA

  • BehavioralTraining evaluation

    Clinicians will complete an evaluation assessing the empathic communication training module.

  • BehavioralPatient recruitment

    6 of the clinician's patients (3 pre-training, 3 post-training) will be recruited to complete brief surveys assessing clinician communication

06

What researchers measure

Primary outcomes

  1. Part 1: Systematic coding of clinical encounters and the perceived stigma within the clinical consultation

    interview along with patient-reported data from the post-consultation questionnaire will be used.

    Time frame: 1 year

  2. Part 1: All variables (stigma, satisfaction with communication, psychological distress)

    will be measured via post-consultation questionnaires

    Time frame: 1 year

  3. Part 2: We will pilot test the effectiveness of the empathic communication skills training module

    for clinicians: physicians, nurse practitioners, physician assistants, fellows, residents, clinical nurses, and clinical nurse specialists by using the communication skills training module

    Time frame: 1 year

Secondary outcomes

  1. # of patients referred to MSK's Tobacco Treatment Program (TTP)

    will be determined via review of the medical record and/or Tobacco Treatment Program database

    Time frame: 1 year

07

Study locations

7 sites
  • Memorial Sloan Kettering Basking Ridge (Consent and follow-up only)
    Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and follow-up only)
    Middletown, New Jersey 07748, United States
  • Memorial Sloan Kettering Bergen (Consent and follow-up only)
    Montvale, New Jersey 07645, United States
  • Memorial Sloan Kettering Commack (Consent and follow-up only)
    Commack, New York 11725, United States
  • Memorial Sloan Kettering Westchester (Consent and follow-up only)
    Harrison, New York 10604, United States
  • Memorial Sloan Kettering Cancer Center
    New York, New York 10065, United States
  • Memorial Sloan Kettering Nassau (Consent and Follow-Up only)
    Uniondale, New York 11553, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2016 (actual). Primary completion is estimated for Jan 2027, 132 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 14, 2016
First posted
Apr 11, 2016
StartActual
Jan 2016
Primary completionEst.
Jan 2027
CompletionEst.
Jan 2027
Last update
Feb 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02732834
Responsible party
Sponsor
First posted
Apr 11, 2016
Start date
Jan 2016
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Feb 5, 2026

Study contacts

Jamie Ostroff, PhD
principal investigator · Memorial Sloan Kettering Cancer Center
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion